Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of E3810 in Non-erosive Gastroesophageal Reflux Disease
NCT00165646Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Sep 2004
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in Non-erosive Gastroesophageal Reflux Disease (NERD), sponsored by Eisai Co., Ltd.. Started Sep 2004; status: completed.
02
Drugs
rabeprazole
03
Conditions
Non-erosive Gastroesophageal Reflux Disease (NERD)
Beyond the preview
Go deeper on NCT00165646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00165646.